Achieve Life Sciences (ACHV) Cash from Financing Activities (2010 - 2026)

Achieve Life Sciences (ACHV) has 17 years of Cash from Financing Activities data on file, last reported at $21000.0 in Q1 2026.

• Quarterly Cash from Financing Activities changed N/A year-over-year to $21000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11.0 million (changed N/A YoY) and the FY2025 annual result came in at $51.5 million, up 6.18% from the prior year.
• Cash from Financing Activities fell to $21000.0 in Q1 2026, from $6.3 million in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $56.1 million in Q1 2024 to a low of -$8.1 million in Q3 2024.
• A 5-year average of $7.2 million and a median of $682000.0 in 2024 frame the typical range for Cash from Financing Activities.
• The widest YoY moves for Cash from Financing Activities: up 119282.98% in 2024, down 101.0% in 2024.
• Tracing ACHV's Cash from Financing Activities over 5 years: stood at $17.7 million in 2022, then decreased by 14.01% to $15.2 million in 2023, then plunged by 95.52% to $682000.0 in 2024, then surged by 818.33% to $6.3 million in 2025, then sank by 99.66% to $21000.0 in 2026.
• The last three Cash from Financing Activities figures came in at $21000.0 (Q1 2026), $6.3 million (Q4 2025), and $4.0 million (Q3 2025), per Business Quant data.